Autoimmune Dysautonomia Evaluation

Autoimmune Dysautonomia^1,2

July 2012

Autoimmune dysautonomia may present as what is known as pandysautonomia meaning that multiple components of the autonomic nervous system are affected or may present with a limited dysautonomia where the disorder is restricted to one or two areas only. Oncological associations of autoimmune dysautonomias include small cell carcinoma, thymoma and other neoplasms.  Over 60% of patients will improve with immunotherapy particularly if treated early.

< Previous Slide

Autoimmune Dysautonomia1,2

Next Slide >

 

Jump to section:

• Introduction
• New Profile
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia^1,2
• Pandysautonomia
• Limited Dysautonomia³
• Objective Testing
• Thermoregulatory Sweat Testing: Measuring Heat-Induced Sweating
• Antibody Testing in Autoimmune Dysautonomia
• Antibody Testing in Autoimmune Dysautonomia
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody
• Ganglionic AChR Autoantibody
• Autoimmune Dysautonomia Antibody Profile
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• ADE/89904 Autoimmune Dysautonomia Evaluation, Serum Algorithm
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Summary
• References
• Questions